Literature DB >> 26956637

Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness.

Joshua Schulman-Marcus1, Parag Goyal2, Rajesh V Swaminathan2, Dmitriy N Feldman2, Shing-Chiu Wong2, Harsimran S Singh2, Robert M Minutello2, Geoffrey Bergman2, Luke K Kim2.   

Abstract

Patients with severe mental illness (SMI), including schizophrenia and bipolar disorder, are at elevated risk of ST-elevation myocardial infarction (STEMI) but have previously been reported as less likely to receive revascularization. To study the persistence of these findings over time, we examined trends in STEMI incidence, revascularization, and in-hospital mortality for patients with and without SMI in the National Inpatient Sample from 2003 to 2012. We further used multivariate logistic regression analysis to assess the odds of revascularization and in-hospital mortality. SMI was present in 29,503 of 3,058,697 (1%) of the STEMI population. Patients with SMI were younger (median age 58 vs 67 years), more likely to be women (44% vs 38%), and more likely to have several co-morbidities, including diabetes, chronic pulmonary disease, substance abuse, and obesity (p <0.001 for all). Over time, STEMI incidence significantly decreased in non-SMI (p for trend <0.001) but not in SMI (p for trend 0.14). Revascularization increased in all subgroups (p for trend <0.001) but remained less common in SMI. In-hospital mortality decreased in non-SMI (p for trend = 0.004) but not in SMI (p for trend 0.10). After adjustment, patients with SMI were less likely to undergo revascularization (odds ratio 0.59, 95% CI 0.52 to 0.61, p <0.001), but SMI was not associated with increased in-hospital mortality (odds ratio 0.97, 95% CI 0.93 to 1.01, p = 0.16). In conclusion, in contrast to the overall population, the incidence of STEMI is not decreasing in patients with SMI. Despite changes in the care of STEMI, patients with SMI remain less likely to receive revascularization therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26956637     DOI: 10.1016/j.amjcard.2016.02.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Mortality and Revascularization among Myocardial Infarction Patients with Schizophrenia: A Population-Based Cohort Study.

Authors:  Tanya S Hauck; Ning Liu; Harindra C Wijeysundera; Paul Kurdyak
Journal:  Can J Psychiatry       Date:  2020-02-04       Impact factor: 4.356

2.  Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.

Authors:  Pirathiv Kugathasan; Henriette Thisted Horsdal; Jørgen Aagaard; Svend Eggert Jensen; Thomas Munk Laursen; René Ernst Nielsen
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

3.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis.

Authors:  Joe Kwun Nam Chan; Ryan Sai Ting Chu; Chun Hung; Jenny Wai Yiu Law; Corine Sau Man Wong; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

4.  The impact of comorbid severe mental illness and common chronic physical health conditions on hospitalisation: A systematic review and meta-analysis.

Authors:  Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

Review 5.  Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease.

Authors:  Kevin O'Gallagher; James Th Teo; Ajay M Shah; Fiona Gaughran
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

6.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.

Authors:  Wing Chung Chang; Joe Kwun Nam Chan; Corine Sau Man Wong; JoJo Siu Han Hai; Philip Chi Fai Or; Eric Yu Hai Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

7.  Effect of charted mental illness on reperfusion therapy in hospitalized patients with an acute myocardial infarction in Florida.

Authors:  Thomas R Campi; Sharon George; Diego Villacís; Melissa Ward-Peterson; Noël C Barengo; Juan C Zevallos
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; R Nesvåg; L Balteskard; J G Bramness; C M Hultman; Ø Naess; T Reichborn-Kjennerud; E Ystrom; B K Jacobsen; A Høye
Journal:  Acta Psychiatr Scand       Date:  2020-02-29       Impact factor: 6.392

9.  Out-of-Hospital Cardiac Arrest in Patients With and Without Psychiatric Disorders: Differences in Use of Coronary Angiography, Coronary Revascularization, and Implantable Cardioverter-Defibrillator and Survival.

Authors:  Carlo Alberto Barcella; Grimur Høgnason Mohr; Kristian Hay Kragholm; Thomas Alexander Gerds; Svend Eggert Jensen; Christoffer Polcwiartek; Mads Wissenberg; Freddy Knudsen Lippert; Christian Torp-Pedersen; Lars Vedel Kessing; Gunnar Hilmar Gislason; Kathrine Bach Søndergaard
Journal:  J Am Heart Assoc       Date:  2019-08-17       Impact factor: 5.501

10.  Medical comorbidities in patients with serious mental illness: a retrospective study of mental health patients attending an outpatient clinic in Qatar.

Authors:  Monica Zolezzi; Sara Abdulrhim; Nour Isleem; Farah Zahrah; Yassin Eltorki
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-15       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.